References

1. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol 1981; 107(1):1-11.

2. Cook SP, Macartney KK, Rose CD, et al. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997; 18(5):320-323.

3. Peltomaa M, Pyykko I, Seppala I, et al. Lyme borreliosis and facial paralysis—a prospective analysis of risk factors and outcome. Am J Otolaryngol 2002; 23(3):125-132.

4. Bingham PM, Galetta SL, Athreya B, et al. Neurologic manifestations in children with Lyme disease. Pediatrics 1995; 96(6):1053-1056.

5. Angerer M, Pfadenhauer K, Stohr M. Prognosis of facial palsy in Borrelia burgdorferi meningopolyradiculoneuritis. J Neurol 1993; 240(5):319-321.

6. http://www.cdc.gov/epo/dphsi/casedef/syphiliscurrent.htm (accessed October 2005).

7. Johnson RA, White M. Syphilis in the 1990s: cutaneous and neurologic manifestations. Semin Neurol 1992; 12(4):287-298.

8. Cintron R, Pachner AR. Spirochetal diseases of the nervous system. Curr Opin Neurol 1994; 7(3):217-222.

9. Verduijn PG, Bleeker JD. Secondary syphilis of the facial nerve. Arch Otolaryngol 1982; 108(6):382-384.

10. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/hansens_t.htm (accessed October 2005).

11. Selby RC. Neurosurgical aspects of leprosy. Surg Neurol 1974; 2(3):165-177.

12. Antia NH, Divekar SC, Dastur DK. The facial nerve in leprosy. I. Clinical and operative aspects. Int J Lepr Other Mycobact Dis 1966; 34(2):103-117.

13. Reichart PA, Srisuwan S, Metah D. Lesions of the facial and trigeminal nerve in leprosy. An evaluation of 43 cases. Int J Oral Surg 1982; 11(1):14-20.

14. Beardwell A. Facial palsy due to the mumps virus. Br J Clin Pract 1969; 23(1):37-38.

15. Manning JJ, Adour KK. Facial paralysis in children. Pediatrics 1972; 49(1):102-109.

16. Endo A, Izumi H, Miyashita M, et al. Facial palsy associated with mumps parotitis. Pediatr Infect Dis J 2001; 20(8):815-816.

17. http://www.mass.gov/dph/cdc/tb/ (accessed October 2005).

18. Stone JW. Tuberculosis of the middle ear. Arch Otolaryngol 1967; 86(4):407-411.

19. Skolnik PR, Nadol JB Jr, Bake AS. Tuberculosis of the middle ear: review of the literature with an instructive case report. Rev Infect Dis 1986; 8(3):403-410.

20. Lucente FE, Tobias GW, Parisier SC, et al. Tuberculosis otitis media. Laryngoscope 1978; 88(7 pt 1):1107—1116.

21. Samuel J, Fernandes CM. Tuberculous mastoiditis. Ann Otol Rhinol Laryngol 1986; 95(3 pt 1):264—266.

22. Singh B. Role of surgery in tuberculous mastoiditis. J Laryngol Otol 1991; 105(11):907-915.

23. Harbert F, Riordan D. Tuberculosis of the middle ear. Laryngoscope 1964; 74:198-204.

24. Windle-Taylor PC, Bailey CM. Tuberculosis otitis media: a series of 22 patients. Laryngoscope 1980; 90(6 pt 1):1039-1044.

25. Plester D, Pusalkar A, Steinbach E. Middle ear tuberculosis. J Laryngol Otol 1980;94(12): 1415-1421.

26. Legent F, Baron F. Facial paralysis and tuberculosis otitis. Significance of early neural decompression. Ann Otolaryngol Chir Cervicofac 1975; 92(4-5):235-240.

27. van der Flier M, van Koppenhagen C, Disch FJ, et al. Bilateral sequential facial palsy during chickenpox. Eur J Pediatr 1999; 158(10):807-808.

28. Guldberg-Moller J, Olsen S, Kettel K. Histopathology of the facial nerve in herpes zoster oticus. AMA Arch Otolaryngol 1959; 69(3):266-275.

29. Muecke M, Amedee RG. Herpes zoster oticus: diagnosis and management. J La State Med Soc 1993; 145(8):333-335.

30. Dickins JR, Smith JT, Graham SS. Herpes zoster oticus: treatment with intravenous acyclovir. Laryngoscope 1988; 98(7):776-779.

31. Uri N, Greenberg E, Meyer W, et al. Herpes zoster oticus: treatment with acyclovir. Ann Otol Rhinol Laryngol 1992; 101(2 pt 1):161-162.

32. May M, Blumenthal F. Herpes zoster oticus: surgery based upon prognostic indicators and results. Laryngoscope 1982; 92(1):65-67.

33. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124(1 pt 1):27-30.

34. Friedman RA. The surgical management of Bell's palsy: a review. Am J Otol 2000; 21(1):139-144.

35. May M, Hughes GB. Facial nerve disorders: update 1987. Am J Otol 1987; 8(2):167-180.

36. Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105(5):371-378.

37. Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell's palsy. Laryngoscope 1999; 109(8):1177-1188.

38. Foy HM, Kenny GE, McMahan R, et al. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA 1970; 214(9):1666-1672.

39. Levine DP, Lerner AM. The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am 1978; 62(5):961-978.

40. Murray HW, Masur H, Senterfit LB, et al. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med 1975; 58(2):229-242.

41. Yesnick L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med 1956; 97(1):93-98.

42. Endtz LJ, Hers JF. Mycoplasma pneumoniae polyradiculitis. Lancet 1970; 1(7642):358.

43. Ernster JA. Bilateral facial nerve paralysis associated with Mycoplasma pneumonia infection. Ear Nose Throat J 1984; 63(12):585-590.

44. Klar A, Gross-Kieselstein E, Hurvitz H, et al. Bilateral Bell's palsy due to Mycoplasma pneumoniae infection. Isr J Med Sci 1985; 21(8):692-694.

45. Falk W. The 1950 Poliomyelitis Epidemic. Acta Med Orient 1951; 10:105.

46. Marberg K. Observations on poliomyelitis during the 1950 epidemic in Israel. Acta Med Orient 1952; 11(4):61-77.

47. Agius T, Bartolo AE, Coleiro C, et al. Clinical Features of Poliomyelitis Epidemic in Malta, 19421943. Br Med J 1945; 1:759.

48. Winter ST. Facial paralysis in poliomyelitis; a follow-up of 58 patients. Pediatrics 1957;

49. Moore EW. The fate of the face in poliomyelitis. Lancet 1952; 1(22):1092-1093.

50. Carpenter CCJ. Fever and febrile syndromes. In: Andreoli TE, Bennett JC, Carpenter CCJ, Plum F, eds. Cecil Essentials of Medicine. 4th ed. Philadelphia, Pennsylvania: W. B. Saunders Company, 1997:671-672.

51. Silverstein A, Steinberg G, Nathanson M. Nervous system involvement as the heralding and-or major manifestation of infectious mononucleosis. Trans Am Neurol Assoc 1971; 96:16-20.

52. Gsell O. Meningitis serosa bei pfeiffer—schem drusenfieber (mononucleosis infectiosa). Dtsch Med Wochenschr 1937; 63:1759-1762.

53. Grose C, Feorino PM, Dye LA, et al. Bell's palsy and infectious mononucleosis. Lancet 1973; 2(7823):231-232.

54. Michel RG, Pope TH Jr, Patterson CN. Infectious mononucleosis, mastoiditis, and facial paralysis. Arch Otolaryngol 1975; 101(8):486-489.

55. Snyderman NL. Otorhinolaryngologic presentations of infectious mononucleosis. Pediatr Clin North Am 1981; 28(4):1011-1016.

56. Weintraub MI. Bilateral facial palsy. A rare presentation of infectious mononucleosis. Clin Pediatr (Phila) 1977; 16(12):1158-1159.

57. Johnson PA, Avery C. Infectious mononucleosis presenting as a parotid mass with associated facial nerve palsy. Int J Oral Maxillofac Surg 1991; 20(4):193-195.

58. Strauss M. Cytomegalovirus and the otolaryngologist. Laryngoscope 1981; 91(12):1995-2006.

59. Leonard J, Tobin J. Polyneuritis associated with CMV infections. Q J Med 1971; 40:435-442.

60. Mair IW, Traavik T. Peripheral facial palsy and viral replication. Acta Otolaryngol 1983; 95(5-6):528-531.

61. Sene-Diouf F, Ndiaye M, Diop AG, et al. Epidemiological, clinical and progressive aspects of neurological manifestations associated with retroviral infections: eleven year retrospective study. Dakar Med 2000; 45(2):162-166.

62. Schielke E, Pfister HW, Einhaupl KM. Peripheral facial nerve palsy associated with HIV infection. Lancet 1989; 1(8637):553-554.

63. Belec L, Georges AJ, Vuillecard E, et al. Peripheral facial paralysis indicating HIV infection. Lancet 1988; 2(8625):1421-1422.

64. Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol 1991; 12 (6):450-451.

65. Walter RS, Eppes SC. Cat scratch disease presenting with peripheral facial nerve paralysis. Pediatrics 1998; 101(5):E13.

66. Premachandra DJ, Milton CM. Cat scratch disease in the parotid gland presenting with facial paralysis. Br J Oral Maxillofac Surg 1990; 28(6):413-415.

67. Yose M, Nishihira O, Inoue S, et al. Facial nerve palsy due to cat scratch disease. Facial Nerve Res 1985; 5:167-169.

68. Jagoda A, Riggio S, Burguieres T. Cephalic tetanus: a case report and review of the literature. Am J Emerg Med 1988; 6(2):128-130.

69. Vakil B.J, Singhal BS, Pandya SS, et al. Cephalic tetanus. Neurology 1973; 23(10):1091-1096.

70. Rose E. Der starrkrampf beim menschen. Deutsche Chirurgie 1897; 3:358-374.

71. Russel BW. Diseases of the Nervous System. 3rd ed. London: Oxford University Press, 1948:783.

72. Binet T. Sur le tetanus cephalique. Rev Chir (Paris) 1909; 50:427-439.

73. Brunner C. Experimentelle und klinische studien uber den kopftetanus. Zuricher Chirurgishchen Klinik 1894; 11:307-348.

74. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988; 85(3):391-398.

75. al Dousary S, Attallh M, al Rabah A, et al. Otitis externa malignant. A case report and review of literature. Otolaryngol Pol 1998; 52(1):19-22.

76. Hybels RL, Rice DH. Neuro-otologic manifestations of sarcoidosis. Laryngoscope 1976; 86(12):1873-1878.

77. James DG. Differential diagnosis of facial nerve palsy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14 (2):115-120.

78. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157(16):1864-1868.

79. Glocker FX, Seifert C, Lucking CH. Facial palsy in Heerfordt's syndrome: electrophysiological localization of the lesion. Muscle Nerve 1999; 22(9):1279-1282.

80. Bopp FP, Cheney ML, Donzis PB, et al. Heerfordt syndrome: a cause of facial paralysis. J La State Med Soc 1990; 142(2):13-15.

81. Dutt SN, Mirza S, Irving RM, et al. Total decompression of facial nerve for Melkersson-Rosenthal syndrome. J Laryngol Otol 2000; 114(11):870-873.

82. Tamaki H, Ogino S, Miyaguchi M. Recurrent facial palsy. In: Graham M, House W, eds. Disorders of the Facial Nerve. New York, New York: Raven Press, 1982:243-248.

83. Graham MD, Kemink JL. Total facial nerve decompression in recurrent facial paralysis and the Melkersson-Rosenthal syndrome: a preliminary report. Am J Otol 1986; 7(1):34-37.

84. http://www.guillain-barre.com/overview.html (accessed October 2005).

85. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994; 44(7):1198-1202.

86. Guillain G. Les Polyradiculonevrites avec dissociation albumino cytologique et a evolution favorable (syndrome de Guillain et Barre). J Belge Neurol Psychiatr 1938; 38:323-329.

87. Shuaib A, Becker WJ. Variants of Guillain-Barre syndrome: Miller Fisher syndrome, facial diplegia and multiple cranial nerve palsies. Can J Neurol Sci 1987; 14(4):611-616.

88. Tos M. Facial palsy in Hand-Schuller-Christian's disease. Arch Otolaryngol 1969; 90(5):563-567.

89. Alexander EL. Central nervous system (CNS) manifestations of primary Sjogren's syndrome: an overview. Scand J Rheumatol Suppl 1986; 61:161-165.

90. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83(5):280-291.

91. Fukazawa T. Facial palsy in multiple sclerosis. J Neurol 1997; 244(10):631-633.

92. Adelman DC, Saltiel E, Klinenberg JR. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986; 15(3):185—199.

93. Feinglass EJ, Arnett FC, Dorsch CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976; 55(4):323-339.

94. Blaustein DA, Blaustein SA. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. J Rheumatol 1998; 25(4):798-800.

95. Carpenter RJ III, McDonald TJ, Howard FM Jr. The otolaryngologic presentation of amyotrophic lateral sclerosis. Otolaryngology 1978; 86(3 pt 1):479-484.

96. Sharp G. Mixed connective tissue disease. Bull Rheum Dis 1975; 25:828-831.

97. Nitsche A, Leiguarda RC, Maldonado Cocco JA, et al. Neurological features in overlap syndrome. Clin Rheumatol 1991; 10(1):5-9.

98. Alfaro-Giner A, Penarrocha-Diago M, Bagan-Sebastian JV. Orofacial manifestations of mixed connective tissue disease with an uncommon serologic evolution. Oral Surg Oral Med Oral Pathol 1992; 73(4):441-444.

99. Hamza M, Annabi A, Ayed K, et al. Mixed connective tissue disease (Sharp syndrome) with involvement of the trigeminal nerve and facial paralysis. Sem Hop 1983; 59(36):2555-2556.

100. Per-Lee JH, Parsons RC. Vasculitis presenting as otitis media. South Med J 1969; 62(2):161-165.

101. Rose GA, Spencer H. Polyarteritis nodosa. Q J Med 1957; 26(101):43-81.

102. Dudley JP, Goodman M. Periarteritis nodosa and bilateral facial paralysis. Arch Otolarygnol 1969; 90(2):139-146.

103. Drinias V, Florentzson R. Facial palsy and Wegener's granulomatosis. Am J Otolaryngol 2004; 25

104. de Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58(8):1215-1221.

105. Nishino H, Rubino FA, DeRemee RA, et al. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33(1):4-9.

106. McCaffrey TV, McDonald TJ, Facer GW, et al. Otologic manifestations of Wegener's granulomatosis. Otolaryngol Head Neck Surg 1980; 88(5):586-593.

107. Dagum P, Roberson JB Jr. Otologic Wegener's granulomatosis with facial nerve palsy. Ann Otol Rhinol Laryngol 1998; 10(7):555-559.

108. Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope 1982; 92(7 pt 1):713-717.

109. Calonius IH, Christensen CK. Hearing impairment and facial palsy as initial signs of Wegener's granulomatosis. J Laryngol Otol 1980; 94(6):649-657.

110. Bibas A, Fahy C, Sneddon L, et al. Facial paralysis in Wegener's granulomatosis of the middle ear. J Laryngol Otol 2001; 115(4):304-306.

111. Bakshi SH, Oak JL, Chawla KP, et al. Facial nerve involvement in pseudotumor cerebri. J Postgrad Med 1992; 38(3):144-145.

112. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache 1997; 37(5):286-288.

113. Amano S, Hazama F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 1980; 30(3):365-373.

114. Poon LK, Lun KS, Ng YM. Facial nerve palsy and Kawasaki disease. Hong Kong Med J 2000; 6 (2):224-226.

115. Park MS, Lee HY, Kim HM, et al. Facial nerve paralysis associated with Kawasaki disease. Yonsei Med J 1991; 32(3):279-282.

116. Little KH, Lee EL, Frenkel EP. Cranial nerve deficits due to amyloidosis associated with plasma cell dyscrasia. South Med J 1986; 79(6):677-681.

117. Traynor AE, Gertz MA, Kyle RA. Cranial neuropathy associated with primary amyloidosis. Ann Neurol 1991; 29(4):451-454.

118. Braganza RA, Tien R, Hoffman HT, et al. Amyloid of the facial nerve. Laryngoscope 1992; 102(12 pt 1):1372-1376.

119. Barker DJ, Clough PW, Guyer PB, et al. Paget's disease of bone in 14 British towns. Br Med J 1977; 1(6070):1181-1183.

120. Hullar TE, Lustig LR. Paget's disease and fibrous dysplasia. Otolaryngol Clin North Am 2003; 36

121. Megerian CA, Sofferman RA, McKenna MJ, et al. Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologic sequelae. Am J Otol 1995; 16(4):408-419.

122. Johnston CC Jr, Lavy N, Lord T, et al. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) 1968; 47(2):149-167.

123. Dort JC, Pollak AC, Fisch U. The fallopian canal and facial nerve in sclerosteosis of the temporal bone: a histopathologic study. Am J Otol 1990; 11(5):320-325.

124. Hofmeyr LM, Hamersma H. Sclerosing bone dysplasias: neurologic assessment and management. Curr Opin Otolaryngol Head Neck Surg 2004; 12(5):393-397.

125. Miyamoto RT, House WF, Brackmann DE. Neurotologic manifestations of the osteopetroses. Arch Otolaryngol 1980; 106(4):210-214.

126. Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004; 30(4):410-422.

127. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998; 18(1):43-52.

128. Cavanagh JB, Mellick RS. On the nature of peripheral nerve lesions associated with acute intermittent porphyria. J Neurol Neurosurg Psychiatry 1965; 28:320-327.

129. Weintraub MI. Facial diplegia. Arch Otolaryngol 1976; 102(5):311-312.

130. Spillane JA. The face in neurological diagnosis. Br J Hosp Med 1983; 30(5):321-322, 324-325.

131. Chia LG. Facial weakness without ocular weakness in myasthenia gravis. Muscle Nerve 1988; 11 (2):185-186.

132. Sanders V. Neurologic manifestations of myxoedema. N Engl J Med 1962; 266:599-603.

133. Cox NH, Chew D, Williams JG, et al. Bell's Palsy associated with hypothyroidism. Br J Clin Pract 1985; 39(4):158-159.

134. Earll JM, Kolb FO. Facial paralysis occurring with hypothyroidism. A report of two cases. Calif Med 1967; 106(1):56-58.

135. Watanabe K, Hagura R, Akanuma Y, et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990; 10(1):19-27.

136. Takasu T. A study of the disorder of the nervous system in diabetes mellitus. Adv Neurol Sci 1964; 8:1.

137. Korczyn AD. Bell's palsy and diabetes mellitus. Lancet 1971; 1(7690):108-109.

138. Moxon M. Apoplexy into canal of Fallopius in a case of Bright's disease, causing facial paralysis. Trans Pathol Soc London 1869; 20:420-422.

139. Paine RS. Facial paralysis in children; review of the differential diagnosis and report of ten cases treated with cortisone. Pediatrics 1957; 19(2):303-316.

140. Clarke E, Murphy EA. Neurological manifestations of malignant hypertension. Br Med J 1956; 44 (5005):1319-1326.

141. Lloyd AV, Jewitt DE, Still JD. Facial paralysis in children with hypertension. Arch Dis Child 1966; 41(217):292-294.

142. Amberg S. Hypertension in the young. Am J Dis Child 1929; 37:335-350.

143. Rance CP, Arbus GS, Balfe JW, et al. Persistent systemic hypertension in infants and children. Pediatr Clin North Am 1974; 21(4):801-824.

144. Trompeter RS, Smith RL, Hoare RD, et al. Neurological complications of arterial hypertension. Arch Dis Child 1982; 57(12):913-917.

145. Tirodker UH, Dabbagh S. Facial paralysis in childhood hypertension. J Paediatr Child Health 2001; 37(2):193-194.

146. Voorhees RL, Zeitzer LD, Ross M. Hypertension and associated peripheral facial paralysis. Laryngoscope 1972; 82(5):899-902.

147. Siegler RL, Brewer ED, Corneli HM, et al. Hypertension first seen as facial paralysis: case reports and review of the literature. Pediatrics 1991; 87(3):387-389.

148. Harms MM, Rotteveel JJ, Kar NC, et al. Recurrent alternating facial paralysis and malignant hypertension. Neuropediatrics 2000; 31(6):318-320.

149. Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84(4 pt 1):433-442.

150. Gillman GS, Schaitkin BM, May M, et al. Bell's palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126(1):26-30.

151. Falco NA, Eriksson E. Idiopathic facial palsy in pregnancy and the puerperium. Surg Gynecol Obstet 1989; 169(4):337-340.

152. Rosenbaum RB, Donaldson JO. Peripheral nerve and neuromuscular disorders. Neurol Clin 1994; 12(3):461-478.

153. Cohen Y, Lavie O, Granovsky-Grisaru S, et al. Bell palsy complicating pregnancy: a review. Obstet Gynecol Surv 2000; 55(3):184-188.

154. Pulec JL. Collected letter. Int Corresp Soc Opthalmol Otolaryngol 1974; 19:42-43.

155. Sendi P, Locher R, Bucheli B, et al. Intranasal influenza vaccine in a working population. Clin Infect Dis 2004; 38:974-980.

156. Zhou W, Pool V, DeStefano F, et al. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004; 13(8):505-510.

157. Shaw FE Jr, Graham DJ, Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Am J Epidemiol 1988; 127(2):337-352.

158. Rice JP, Horowitz M, Chin D. Wernicke-Korsakoff syndrome with bilateral facial nerve palsies. J Neurol Neurosurg Psychiatry 1984; 47(12):1356-1357.

159. Zaloga GP, Deal J, Spurling T, et al. Unusual manifestations of arsenic intoxication. Am J Med Sci 1985; 289(5):210-214.

160. McCall WV, Coffey CE. Transient facial palsy during lithium toxicity. J Clin Psychopharmacol 1987; 7(4):280-281.

161. Lee RT, Oster MW, Balmaceda C, et al. Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel. Ann Oncol 1999; 10(10):1245-1247.

162. Sokoloff J, Wickbom I, McDonald D, et al. Therapeutic percutaneous embolization in intractable epistaxis. Radiology 1974; 111(2):285-287.

163. de Vries N, Versluis RJ, Valk J, et al. Facial nerve paralysis following embolization for severe epistaxis (case report and review of the literature). J Laryngol Otol 1986; 100(2):207-210.

164. Metson R, Hanson DG. Bilateral facial nerve paralysis following arterial embolization for epistaxis. Otolaryngol Head Neck Surg 1983; 91(3):299-303.

165. Rhee D, Myssiorek D, Zahtz G, et al. Recurrent attacks of facial nerve palsy as the presenting sign of leukemic relapse. Laryngoscope 2002; 112(2):235-237.

166. Sood BR, Sharma B, Kumar S, et al. Facial palsy as first presentation of acute myeloid leukemia. Am J Hematol 2003; 74(3):200-201.

167. Paparella MM, Berlinge NT, Oda M. Otological manifestations of leukemia. Laryngoscope 1973; 83(9):1510-1526.

168. Zappia JJ, Bunge FA, Koopmann CF Jr, et al. Facial nerve paralysis as the presenting symptom of leukemia. Int J Pediatr Otorhinolaryngol 1990; 19(3):259-264.

169. Gotay V. Unusual otologic manifestations of chronic lymphocytic leukemia. Laryngoscope 1976; 86(12):1856-1863.

170. Schattner A, Kozack N, Sandler A, et al. Facial diplegia as the presenting manifestation of acute lymphoblastic leukemia. Mt. Sinai J Med 2001; 68(6):406-409.

171. Chapman P, Johnson SA. Mastoid chloroma as relapse in acute myeloid leukemia. J Laryngol Otol 1980; 94(12):1423-1427.

172. Ho TP, Carrie S, Meikle D, et al. T-cell lymphoma presenting as acute mastoiditis with a facial palsy. Int J Pediatr Otorhinolaryngol 2004; 68(9):1199-1201.

173. Bockmuhl U, Bruchhage KL, Enzmann H. Primary non-Hodgkin's lymphoma of the temporal bone. Eur Arch Otorhinolaryngol 1995; 252(6):376-378.

174. Tucci DL, Lambert PR, Innes DJ Jr. Primary lymphoma of the temporal bone. Arch Otolaryngol Head Neck Surg 1992; 118(1):83-85.

175. Lang EE, Walsh RM, Leader M. Primary middle-ear lymphoma in a child. J Laryngol Otol 2003; 117(3):205-207.

176. Laubert A, Mausolf A, Bernhards J, et al. Non-Hodgkin's lymphoma: a differential diagnosis of otogenic facial paralysis. HNO 1991; 39(3):98-101.

177. Shone GR. Facial palsy due to myeloma of the temporal bone. J Laryngol Otol 1985; 99(9):907-908.

178. Marks PV, Brookes GB. Myelomatosis presenting as an isolated lesion in the mastoid. J Laryngol Otol 1985; 99(9):903-906.

179. Funakubo T, Kikuchi A. A case of myeloma with facial palsy. Acta Otolaryngol Suppl 1994; 511:200-203.

180. Quinodoz D, Dulguerov P, Kurt AM, et al. Multiple myeloma presenting with external ear canal mass. J Laryngol Otol 1998; 112(5):469-471.

181. Li W, Schachern PA, Morizono T, et al. The temporal bone in multiple myeloma. Laryngoscope 1994; 104(6 pt 1):675-680.

182. Schuuknecht HF. Neoplastic growth. In: Schuknecht HF, ed. Pathology of the Ear. 2nd ed. Philadelphia, Pennsylvania: Lea and Febiger, 1993:492-498.

Blood Pressure Health

Blood Pressure Health

Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...

Get My Free Ebook


Post a comment